Paradoxes of US psychopharmacology practice in 2013: Undertreatment of severe mental illness and overtreatment of minor psychiatric problems

Journal of Clinical Psychopharmacology

Volumn 34, Issue 5, 2014, Pages 545-548

  De Leon, Jose ^a,b  

^a Eastern State Hospital   (United States)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL OBSERVATION; DRUG INDUSTRY; DRUG MISUSE; DRUG USE; DSM-5; DSM-III; HEALTH CARE SYSTEM; HUMAN; MENTAL DISEASE; MENTAL HEALTH; MENTAL HOSPITAL; PHARMACEUTICAL CARE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOLOGY; REVIEW; UNITED STATES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HEALTH SERVICE; MENTAL DISORDERS; STATISTICS AND NUMERICAL DATA; TRENDS;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; HUMANS; MEDICAL OVERUSE; MENTAL DISORDERS; PSYCHOPHARMACOLOGY; UNITED STATES;

EID: 84907423727     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000126     Document Type: Review

References (35)

1. Lieberman J. Psychiatry: Nothing to be defensive about. Psychiatric News July 17, 2013. Available at: http://psychnews. psychiatryonline.org/newsarticle. aspx?articleid=1715655. Accessed September 27, 2013.
2. Klein DF, Glick ID, Shader RI. Central nervous system drug development, basic, and clinical research: Thinking outside the box. J Clin Psychopharmacol. 2011;31:553-554.
3. Wegener G, Rujescu D. The current development of CNS drug research. Int J Neuropsychopharmacol. 2013;16:1687-1693.
4. Fibiger HC. Psychiatry, the pharmaceutical industry, and the road to better therapeutics. Schizophr Bull. 2012;38:649-650.
5. Brady LS, Insel TR. Translating discoveries into medicine: Psychiatric drug development in 2011. Neuropsychopharmacology. 2012;37:281-283.
6. Insel TR, Scolnick EM. Cure therapeutics and strategic prevention: Raising the bar for mental health research. Mol Psychiatry. 2006;11:11-17.
7. McHugh PR. Psychiatry and its scientific relatives: "a little more than kin and less than kind". J Nerv Ment Dis. 1987;175:579-583.
8. Wilson M. DSM-III and the transformation of American psychiatry: A history. Am J Psychiatry. 1993;150:399-410.
9. Decker HS. How Kraepelinian was Kraepelin? How Kraepelinian are the neo-Kraepelinians?Vfrom Emil Kraepelin to DSM-III. Hist Psychiatry. 2007;18:337-360.
10. Dean CE. The death of specificity in psychiatry: Cheers or tears? Perspect Biol Med. 2012;55:443-460.
11. Frances A. The new crisis of confidence in psychiatric diagnosis. Ann Intern Med. 2013;159:720.
12. Frances A. The past, present and future of psychiatric diagnosis. World Psychiatry. 2013;12:111-112.
13. de Leon J. Is psychiatry scientific? A letter to a 21st century psychiatry resident. Psychiatry Investig. 2013;10:205-217.
14. Frances A, Batstra L. Why so many epidemics of childhood mental disorder? J Dev Behav Pediatr. 2013;34:291-292.
15. Parens E, Johnston J. Understanding the agreements and controversies surrounding childhood psychopharmacology. Child Adolesc Psychiatry Ment Health. 2008;2:5.
16. Mark TL. For what diagnoses are psychotropic medications being prescribed?: A nationally representative survey of physicians. CNS Drugs. 2010;24:319-326.
17. Greenblatt DJ, Harmatz JS, Shader RI. Psychotropic drug prescribing in the United States: Extent, costs, and expenditures. J Clin Psychopharmacol. 2011;31:1-3.
18. Mark TL, Kassed C, Levit K, et al. An analysis of the slowdown in growth of spending for psychiatric drugs, 1986-2008. Psychiatr Serv. 2012;63:13-18.
19. Mark TL, Levit KR, Buck JA. Datapoints: Psychotropic drug prescriptions by medical specialty. Psychiatr Serv. 2009;60:1167.
20. Le Fanu J. The Rise and Fall of Modern Medicine. New York, NY: Carrol & Graf; 1999.
21. Horvitz-Lennon M, Kilbourne AM, Pincus HA. From silos to bridges: Meeting the general health care needs of adults with severe mental illnesses. Health Aff (Millwood). 2006;25:659-669.
22. Fink M. Rediscovering catatonia: The biography of a treatable syndrome. Acta Psychiatr Scand Suppl. 2013;441:1-47.
23. Healy D, Mangin D. The once and future psychiatry. Acad Med. 2009;84:418-420.
24. Torrey EF. Out of the Shadows: Confronting America's Mental Illness Crisis. New York, NY: Wiley; 1997.
25. Torrey E, Kennard A, Eslinger D, et al. More mentally ill persons are in jails and prisons than hospitals: A survey of the states. Treatment Advocacy Center, May 2010. Available at: http://www.treatmentadvocacycenter.org/storage/ documents/final-jails-v-hospitals-study.pdf. Accessed September 27, 2013.
26. Fields G, Phillips EE. The new asylums: Jails swell with mentally ill.Wall Street Journal. September 26, 2013. Available at: http://online.wsj. com/article/SB10001424127887323455104579012664245550546.html. Accessed September 27, 2013.
27. Knoll JL. The return of the alienist. Medscape. May 10, 2013. Available at: http://www.medscape.com/viewarticle/803662. Accessed September 27, 2013.
28. Swanson JW, Frisman LK, Robertson AG, et al. Costs of criminal justice involvement among persons with serious mental illness in Connecticut. Psychiatr Serv. 2013;64:630-637.
29. de Leon J. A postYDSM-III wake-up call to European psychiatry. Acta Psychiatr Scand. 2014;129:76-77.
30. Berŕos GE. Psychiatry and its objects. Rev Psiquiatr Salud Ment. 2011;4:179-182.
31. Van Os J. Solutions for patients depend on whether we can bridge the divide between social and natural science research approaches in the area of mental health. Rev Psiquiatr Salud Ment. 2012;5:135-138.
32. McHugh PR. Striving for coherence: Psychiatry's efforts over classification. JAMA. 2005;293:2526-2528.
33. Marková IS, Berrios GE. Epistemology of mental symptoms. Psychopathology. 2009;42:343-349.
34. de Leon J. The future (or lack of future) of personalized prescription in psychiatry. Pharmacol Res. 2009;59:81-89.
35. de Leon J, Chambers A, Hyatt M, et al. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. New York, NY: Springer Verlag; 2012.